Eagles QB Michael Vick is "on the verge of signing his biggest endorsement deal since he restarted his NFL career after his incarceration, negotiating with MusclePharm" on a possible three-year, $1.55M deal, according to a source cited by Jason La Canfora of NFL.com. A source indicated that a "deal has been agreed to" with MusclePharm, which makes supplements and workout-related products. MusclePharm Dir of Team Development Joseph Lawanson said that the company "is still considering its options but confirmed that Vick is definitely under consideration." La Canfora reported Vick's deal "would be for two years guaranteed, with an option for a third year and would include substantial bonuses" based on personal and team performance. Vick would have a "social media responsibility with the company and the ease to which he works with MusclePharm executives would help determine whether the third year is picked up." Vick would receive $100,000 in MusclePharm stock per year, and base compensation would be $200,000 in the first two years and $250,000 in the third (NFL.com, 7/12). The MusclePharm deal comes shortly after Vick re-signed with Nike. In Philadelphia, Jonathan Tamari notes after "rehabilitating his image last season, Vick gained some local endorsement deals, but only recently returned to a larger stage in terms of company size and financial terms" (PHILADELPHIA INQUIRER, 7/13).
